Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-18
2011-01-18
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S217000
Reexamination Certificate
active
07872043
ABSTRACT:
The invention relates to the use of one or several synthetic or natural furan alkyls for cosmetically treating cellulite. Said furan alkyls preferably correspond to formula (I), wherein identical or different R1, R2, R3et R4are independently of each other a hydrogen atom, a C1-C35alkyl radical, C1-C35alcenyl radical or a C1-C35alcynyl radical, preferably C10-C22, wherein said alkyl, alcenyl and alcynyl radicals are substitutable and R1, R2, R3are preferably a hydrogen atom.
REFERENCES:
patent: 4127592 (1978-11-01), Cohen
patent: 4594472 (1986-06-01), Brettle et al.
patent: 5262163 (1993-11-01), Rancurel
patent: 5468490 (1995-11-01), Huber et al.
patent: 6030993 (2000-02-01), Jew et al.
patent: 6582688 (2003-06-01), Broutin et al.
patent: 6994875 (2006-02-01), Piccirilli et al.
patent: 2003/0120073 (2003-06-01), Seto
patent: 2004/0029812 (2004-02-01), Boddupalli et al.
patent: 2004/0033506 (2004-02-01), Farrelly et al.
patent: 2005/0048144 (2005-03-01), Han et al.
patent: 2005/0256061 (2005-11-01), Msika et al.
patent: 2006/0122246 (2006-06-01), Msika et al.
patent: 0 046 595 (1982-03-01), None
patent: 0 110 548 (1984-06-01), None
patent: 0 775 480 (1997-05-01), None
patent: 1 020 192 (2000-07-01), None
patent: 2 678 614 (1993-01-01), None
patent: 2 678 632 (1993-01-01), None
patent: WO 01/21605 (2001-03-01), None
patent: WO 02/058698 (2002-08-01), None
patent: WO 03/004484 (2003-01-01), None
patent: WO 03/007888 (2003-01-01), None
patent: WO 2004/002435 (2004-01-01), None
patent: WO 2004/016106 (2004-02-01), None
patent: WO 2004/112741 (2004-12-01), None
Office Action issued Nov. 18, 2008, in U.S. Appl. No. 11/597,635.
Reusch, “Diabestes, microvascular complications, and cardiovascular complications: what is it about glucose?,”J. Clin. Invest., 2003, vol. 112, No. 7, pp. 986-988.
Webster's Dictionary, 1963, Merriam-Webster (Publisher), p. 1798.
Office Action issued on Jul. 28, 2009 by the Examiner in U.S. Appl. No. 11/597,635.
Office Action issued on Nov. 18, 2008 by the Examiner in U.S. Appl. No. 11/597,635.
Notice of Allowance dated Jun. 12, 2009, issued by the Examiner in U.S. Appl. No. 11/597,634.
Office Action dated Oct. 23, 2008, issued by the Examiner in U.S. Appl. No. 11/597,634.
Office action dated Mar. 19, 2008, issued by the Examiner in U.S. Appl. No. 11/597,634.
Office Action dated Jul. 9, 2008, issued by the Examiner in U.S. Appl. No. 11/597,635.
Database CA Online Chemical Abstract Service, XP-002312714, Pleshakov et al., “Arylsulfonic acid salts having hypoglycemic activity,” Database accession No. 121:73898, Aug. 20, 1994.
Database CA Online Chemical Abstract Service, XP-002312713, Takaya et al., “Lipid metabolism-improving pharmaceutical compositions containing furans or thiophenes for prophylactic and therapeutic treatment of hyperlipidemia,” Database accession No. 137:140429, Jul. 31, 2002.
Farines et al., “Influence of Avocado Oil Processing on the Nature of Some Unsaponifiable Constituents,” J. of Am. Oil Chem. Soc., 1995, 72(4), 473-476.
Kim et al., “New Antihypercholesterolemic Agents 2. Synthesis and Biological Activity of Ethyl 7-(2-Furyl)-3,5-dihydroxy-1-heptenoate,” Korean J. of Med. Chem., 1994, 4(1), 10-15.
Perreault et al., “Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle,” Nature Medicine, Oct. 2001, 7(10), 1138-43.
Msika Philippe
Piccardi Nathalie
Piccirilli Antoine
Betton Timothy E
Foley & Lardner LLP
Laboratories Expanscience
Padmanabhan Sreeni
LandOfFree
Use of furan alkyls for a cellulite cosmetic treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of furan alkyls for a cellulite cosmetic treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of furan alkyls for a cellulite cosmetic treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2626153